Status:
COMPLETED
Observational Prospective Study on Patients Treated With Norditropin®
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Growth Hormone Disorder
Growth Hormone Deficiency in Children
Eligibility:
All Genders
Brief Summary
This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of child...
Eligibility Criteria
Inclusion
- Judged by the physician as per the Norditropin® label
Exclusion
- Judged by the physician as per the Norditropin® label
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
21249 Patients enrolled
Trial Details
Trial ID
NCT00960128
Start Date
April 1 2006
End Date
December 31 2016
Last Update
October 12 2017
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Prov. de Buenos Aires, Argentina, B1636DSU
2
Novo Nordisk Investigational Site
Brussels, Belgium, 1070
3
Novo Nordisk Investigational Site
Prague, Czechia, 16000
4
Novo Nordisk Investigational Site
Copenhagen S, Denmark, 2300